SEDDAIU, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 3.044
AS - Asia 1.765
EU - Europa 1.100
SA - Sud America 890
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 49
OC - Oceania 7
Totale 6.912
Nazione #
US - Stati Uniti d'America 2.952
BR - Brasile 789
SG - Singapore 691
CN - Cina 549
UA - Ucraina 319
DE - Germania 155
VN - Vietnam 143
SE - Svezia 114
HK - Hong Kong 106
IT - Italia 105
FR - Francia 95
GB - Regno Unito 88
FI - Finlandia 66
TR - Turchia 53
CZ - Repubblica Ceca 44
CA - Canada 41
IQ - Iraq 34
AR - Argentina 29
IN - India 29
MX - Messico 27
RU - Federazione Russa 25
BE - Belgio 24
ID - Indonesia 21
BD - Bangladesh 18
EC - Ecuador 18
ZA - Sudafrica 17
VE - Venezuela 16
CO - Colombia 15
JP - Giappone 15
PK - Pakistan 14
UZ - Uzbekistan 14
PL - Polonia 12
ES - Italia 11
JO - Giordania 11
IR - Iran 10
MA - Marocco 10
LT - Lituania 9
PY - Paraguay 9
AT - Austria 8
AZ - Azerbaigian 8
KR - Corea 8
KE - Kenya 7
NL - Olanda 7
AU - Australia 6
AE - Emirati Arabi Uniti 5
NP - Nepal 5
PA - Panama 5
SA - Arabia Saudita 5
TN - Tunisia 5
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
HN - Honduras 4
PE - Perù 4
UY - Uruguay 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
IL - Israele 3
MY - Malesia 3
PH - Filippine 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BO - Bolivia 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 6.867
Città #
Dallas 863
Singapore 414
Chandler 370
San Jose 195
Jacksonville 191
Ashburn 124
Beijing 111
Hong Kong 105
Princeton 97
Nanjing 76
Dearborn 75
Council Bluffs 73
Ann Arbor 69
Columbus 60
Sassari 57
Wilmington 52
São Paulo 50
Ho Chi Minh City 48
Lauterbourg 45
Santa Clara 44
Brno 40
Los Angeles 40
Rio de Janeiro 39
Nanchang 37
Hanoi 36
Boardman 34
Shanghai 32
Izmir 27
Munich 26
Woodbridge 26
Changsha 25
Shenyang 25
Brussels 24
Tianjin 21
London 20
Baghdad 16
New York 16
The Dalles 16
Belo Horizonte 15
Tokyo 15
Toronto 15
Zhengzhou 15
Brasília 14
Jiaxing 14
Hebei 13
Helsinki 13
Jinan 13
Porto Alegre 13
Tashkent 13
Campinas 12
Orem 12
Warsaw 12
Amman 11
Hangzhou 11
Nuremberg 11
Chennai 10
Falls Church 10
Ningbo 10
Augusta 9
Boston 9
Brooklyn 9
Frankfurt am Main 9
Guarulhos 9
Johannesburg 9
Mexico City 9
Quito 9
Salvador 9
San Francisco 9
Ardabil 8
Baku 8
Denver 8
Goiânia 8
Guangzhou 8
Leawood 8
Norwalk 8
San Mateo 8
Santo André 8
Seoul 8
Stockholm 8
Turku 8
Andover 7
Biên Hòa 7
Buffalo 7
Da Nang 7
Guayaquil 7
Istanbul 7
Nairobi 7
Ribeirão Preto 7
Taizhou 7
Atlanta 6
Chicago 6
Contagem 6
Curitiba 6
Fortaleza 6
Ipatinga 6
Joinville 6
Kunming 6
Monmouth Junction 6
Montreal 6
Mountain View 6
Totale 4.186
Nome #
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 219
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 198
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis 191
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 190
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 189
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 183
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 179
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-kappa B and Mat1A genes in the early stages of rat liver carcinogenesis 179
INHIBITION OF 3-HYDROXY-3-METHYLGLUTARY-COA REDUCTASE ACTIVITY AND GENE EXPRESSION BY DEHYDROEPIANDROSTERONE IN PRENEOPLASTIC LIVER NODULES 173
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 160
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 160
Experimental models to define the genetic predisposition to liver cancer 160
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 159
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 158
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 158
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 157
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 155
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 154
Chemopreventive N-(4-hidroxyphenyl)retinamide targets NF-kB and Mat1A genes in early stages of rat liver carcinogenesis. 154
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 152
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 151
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 151
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 150
SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis 149
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 145
Chromosome mapping of multiple loci affecting the genetic predisposition to rat liver carcinogenesis 140
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 140
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 139
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 137
The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. 134
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 134
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 133
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 132
Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value 130
Frequent loss of heterozygosity at the Hcr1 (Hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain 130
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 128
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 124
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 122
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 113
The post-transcriptional dysregulation of methionine adenosyl-transferases is crucial for the progression of rat and human liver cancer. 47° Annual Meeting of the European Association for Study of the Liver (EASL) Aprile 18-22, 2012 111
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 111
Inhibition of 3-hydroxy-3- methylglutaryl-CoA reductase activity and gene expression by dehydroepiandrosterone in preneolastic liver nodules 109
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 101
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 101
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 97
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 94
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 91
Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. 45° Annual Meeting of the European Association for the Study of the Liver (EASL) Aprile 14-18, 2010 87
Totale 6.912
Categoria #
all - tutte 27.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022226 0 1 1 5 4 7 20 11 26 22 30 99
2022/2023632 67 64 13 120 51 106 0 69 109 1 19 13
2023/2024162 29 13 1 5 19 3 0 4 0 1 22 65
2024/20251.648 13 20 64 61 77 53 115 314 509 290 92 40
2025/20262.565 134 609 433 299 228 150 332 67 99 132 61 21
2026/2027175 51 124 0 0 0 0 0 0 0 0 0 0
Totale 6.912